Cellular & Molecular Immunology

(The TQCC of Cellular & Molecular Immunology is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications1259
Necroptosis, pyroptosis and apoptosis: an intricate game of cell death821
NLRP3 inflammasome activation and cell death530
Tumor-infiltrating lymphocytes in the immunotherapy era432
The ORF3a protein of SARS-CoV-2 induces apoptosis in cells378
Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities325
An update on the regulatory mechanisms of NLRP3 inflammasome activation322
SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70278
A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity260
Macrophages and the maintenance of homeostasis208
Neutrophils in chronic inflammatory diseases201
Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients196
Gut microbiota-derived metabolites in the regulation of host immune responses and immune-related inflammatory diseases195
The blood–brain barrier in systemic infection and inflammation194
Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors191
Gut microbiome, liver immunology, and liver diseases188
Cancer immunotherapy with γδ T cells: many paths ahead of us188
Dendritic cell migration in inflammation and immunity178
Unique immunological profile in patients with COVID-19173
Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids173
Increased immune escape of the new SARS-CoV-2 variant of concern Omicron172
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells163
Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients159
New insights into the evasion of host innate immunity by Mycobacterium tuberculosis155
Metabolism of tissue macrophages in homeostasis and pathology142
SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response137
SARS-CoV-2-specific T cells in infection and vaccination131
Manganese salts function as potent adjuvants126
Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer122
Activation or exhaustion of CD8+ T cells in patients with COVID-19116
The cutting-edge progress of immune-checkpoint blockade in lung cancer110
Tumor-associated myeloid cells: diversity and therapeutic targeting108
Pathological and molecular examinations of postmortem testis biopsies reveal SARS-CoV-2 infection in the testis and spermatogenesis damage in COVID-19 patients107
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors107
SARS-CoV-2 ORF10 suppresses the antiviral innate immune response by degrading MAVS through mitophagy106
Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response105
Immunological mechanisms and therapeutic targets of fatty liver diseases104
Dendritic cells in cancer immunology103
Shared and distinct roles of T peripheral helper and T follicular helper cells in human diseases102
SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation95
ACOD1 in immunometabolism and disease94
Human immunology and immunotherapy: main achievements and challenges94
Phages and their potential to modulate the microbiome and immunity92
Neutralizing antibodies for the prevention and treatment of COVID-1991
New insights into the cell- and tissue-specificity of glucocorticoid actions88
Neutrophils in liver diseases: pathogenesis and therapeutic targets85
Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies83
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods83
Enhancing CAR-T cell efficacy in solid tumors by targeting the tumor microenvironment83
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection77
Ligand recognition by the γδ TCR and discrimination between homeostasis and stress conditions77
T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant76
Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm75
Immunopathobiology and therapeutic targets related to cytokines in liver diseases75
USP19 suppresses inflammation and promotes M2-like macrophage polarization by manipulating NLRP3 function via autophagy75
Expansion of atypical memory B cells is a prominent feature of COVID-1972
Impact of intracellular innate immune receptors on immunometabolism70
Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia69
Autoimmmune hepatitis69
RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor69
A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract68
“Autoinflammatory psoriasis”—genetics and biology of pustular psoriasis66
T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals66
Microglia as hackers of the matrix: sculpting synapses and the extracellular space65
Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren’s syndrome by modulating the function of myeloid-derived suppressor cells64
Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice64
The essential functions of mitochondrial dynamics in immune cells64
Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion62
The aryl hydrocarbon receptor and the gut–brain axis62
Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis61
IFNγ signaling integrity in colorectal cancer immunity and immunotherapy60
The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy60
HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy60
The roles of microglia in viral encephalitis: from sensome to therapeutic targeting59
Protein N-myristoylation: functions and mechanisms in control of innate immunity56
Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine56
The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-3356
Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantation55
Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-1953
Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy53
Protein synthesis, degradation, and energy metabolism in T cell immunity51
Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice51
OTUD5 promotes innate antiviral and antitumor immunity through deubiquitinating and stabilizing STING51
Biology and pathology of the uterine microenvironment and its natural killer cells48
Clinical development of CAR T cell therapy in China: 2020 update48
Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer47
Diet, lipids, and antitumor immunity47
A novel CD4+ CTL subtype characterized by chemotaxis and inflammation is involved in the pathogenesis of Graves’ orbitopathy46